Objective To construct the recombinant modified vacinia Ankara(rMVA)for stable and high expression of HIV-1 Gag-Pol antigen and study its humoral immune effect.

• 目的构建稳定高效表达HIV-1Gag-Pol蛋白的重组痘病毒载体疫苗,并检测其体液免疫效果。